HC Wainwright & Co. Reiterates Buy on Gossamer Bio, Maintains $2 Price Target

Gossamer Bio

Gossamer Bio

GOSS

0.00

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Gossamer Bio (NASDAQ: GOSS) with a Buy and maintains $2 price target.